Actively Recruiting

Phase Not Applicable
Age: 65Years +
All Genders
ID06360432

Effects of the EatWelLog App on Enhancing Daily Diet Management for Community-dwelling Older Adults With Sarcopenic Obesity: A Pilot Randomized Controlled Trial

Led by The Hong Kong Polytechnic University · Updated on 2025-02-13

40

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Sarcopenic obesity (SO) is a condition where older adults experience both reduced muscle mass and excess body fat, affecting a significant portion of this population and increasing risks for health issues like osteoarthritis and cardio-metabolic diseases. This research evaluates the EatWellLog App, designed to help older adults with SO improve their muscle strength, body composition, and overall health through better diet management and exercise adherence. The study compares the effects of using this app alongside standard interventions to those of standard care alone. Participants will be randomly assigned to either the M-health group, which receives an 8-week supervised program including personalized dietary modification, group exercise training, and daily use of the EatWellLog App for diet self-management, or to the control group, which receives the same 8-week dietary and exercise program without the app. The dietary program encourages moderate calorie reduction with adequate protein intake, and the exercise program combines resistance and aerobic training. The app provides dietary tracking, personalized coaching, family support, educational content, and engagement features to support lifestyle changes. Participants will be assessed at baseline, immediately after the 8-week program, and at 3 and 6 months follow-up. Measurements include muscle strength, muscle mass, body mass index, waist circumference, fat mass, physical performance via the Short Physical Performance Battery, nutritional status, diet quality, quality of life, and adherence to diet and exercise. The study also collects app usage data and user experiences to understand engagement and longer-term impact. The total participation duration includes the initial program and follow-up assessments over six months.

CONDITIONS

Brief Title

Effects of the EatWelLog App on Diet Management for Older Adults With Sarcopenic Obesity

Who Can Participate

Age: 65Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 65 or above and living in the community
  • Diagnosed with sarcopenic obesity according to Asian Working Group for Sarcopenia and WHO obesity criteria for Asians
  • Early-stage sarcopenia indicated by low handgrip strength, low muscle mass, or low physical performance (SPPB score <9)
  • Obesity indicated by BMI ≥25 kg/m2, waist circumference ≥90 cm (men) or ≥80 cm (women), or body fat >30%
  • Own a smartphone with internet access
  • Able to communicate, read, and write in Chinese without major hearing or vision impairments
Not Eligible

You will not qualify if you...

  • Having severe cardiac, pulmonary, renal diseases, diabetes, cancer, or autoimmune disorders
  • Using medications that affect eating habits, digestion, or metabolism such as weight loss drugs
  • Diagnosed with alcohol use disorder
  • Having medical implants like pacemakers that interfere with bioelectric impedance analysis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 8 weeks

Participants receive an 8-week program consisting of personalized dietary modification sessions and group-based exercise training. The dietary program includes eight one-hour face-to-face sessions focusing on a moderate hypocaloric diet with high protein intake to encourage steady weight loss while preserving muscle mass. The exercise training includes weekly one-hour group sessions combining resistance and aerobic workouts to improve muscle mass, strength, and reduce fat. Participants in the M-health group also use the EatWellLog app daily for diet self-management during this period.

8 dietary modification sessions and 8 weekly exercise group sessions

Follow-up

Duration - 4 months

Participants are followed up to assess lasting effects on sarcopenic obesity status and other health outcomes at 3 and 6 months after completing the treatment program.

Visits at 3 months and 6 months post-treatment

Trial Site Locations

Total: 1 location

1

The Hong Kong Polytechnic University

Hong Kong, Hong Kong

Actively Recruiting

Loading map...

Research Team

J

Justina Liu, PhD

A

Amy Cheung

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Adverse Outcomes and Mortality in Liver Transplant Using MRI...

End Stage Liver DIsease

Actively Recruiting

1 location

Dissecting the Molecular and Cellular Pathophysiology of Sar...

Sarcopenic Obesity

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

The combination of dynapenia and abdominal obesity as a risk factor for worse trajectories of IADL disability among older adults.

Tiago da Silva Alexandre, Shaun Scholes, Jair Licio Ferreira Santos...

https://pubmed.ncbi.nlm.nih.gov/29033231

Effects of Nutrition and Exercise Interventions on Persons with Sarcopenic Obesity: An Umbrella Review of Meta-Analyses of Randomised Controlled Trials.

Lea Reiter, Silvia Bauer, Mariella Traxler...

https://pubmed.ncbi.nlm.nih.gov/37249818

Nutritional and exercise interventions in individuals with sarcopenic obesity around retirement age: a systematic review and meta-analysis.

Doris Eglseer, Mariella Traxler, Josje D Schoufour...

https://pubmed.ncbi.nlm.nih.gov/36882046